You are here

Article info

Article menu
Download PDFPDF
Review
Semaglutide: a new drug for the treatment of obesity

Authors

  • Joel Lexchin School of Health Policy and Management, York University – Keele Campus, Toronto, Ontario, Canada Department of Family and Community Medicine, University of Toronto, Toronto, Ontario, Canada PubMed articlesGoogle scholar articles
  • Barbara Mintzes School of Pharmacy and Charles Perkins Centre, The University of Sydney Faculty of Medicine and Health, Sydney, New South Wales, Australia The University of British Columbia School of Population and Public Health, Vancouver, British Columbia, Canada PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Joel Lexchin, School of Health Policy and Management, York University - Keele Campus, Toronto, ON M3J 1P3, Canada; jlexchin{at}yorku.ca
View Full Text

Citation

Lexchin J, Mintzes B
Semaglutide: a new drug for the treatment of obesity
Drug and Therapeutics Bulletin 2023;61:182-188.

Publication history

  • First published October 25, 2023.
Online issue publication 
November 29, 2023

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.